Market revenue in 2022 | USD 3,327.7 million |
Market revenue in 2030 | USD 5,754.4 million |
Growth rate | 7.1% (CAGR from 2022 to 2030) |
Largest segment | Cdna synthesis & conversion |
Fastest growing segment | Data Analysis & Interpretation |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation |
Key market players worldwide | Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.
Cdna synthesis & conversion was the largest segment with a revenue share of 27.03% in 2022. Horizon Databook has segmented the Asia Pacific gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is poised to witness fastest growth over the forecasted period owing to rising interest of dominant players in emerging markets, such as China & India. Sequencing and array technologies are widely adopted in this region owing to increased genomic and gene-related studies.
Furthermore, the region is expected to exhibit fastest growth due to rising government intervention for improvement of healthcare and increasing adoption of advanced diagnostic tests in developing countries.
China is expected to be the largest contributor because of its strategic partnership with prominent players in the west. Increased investments in proteomic & genomic research, rise in healthcare expenditure, rising interest of key players in emerging markets, and demand for efficient diagnostic tests are expected to fuel growth in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific gene expression market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account